After 2024, which saw a steady recovery by the life sciences industry, it looks like 2025 is set to be a year of change and development, particularly in clinical trials. The good news is that ...

Yet, some use cases can be more easily applied to almost every clinical trial organisation. This article outlines some practical GenAI use cases in clinical trials and discusses the most popular ...

Clinical pharmacology is a branch of biomedical science. It includes drug discovery, the study of the effects of drugs on their targets in living systems and their clinical use, as well as the ...

We tested more than 110 sunscreens over the course of six weeks and ranked them. See which brands like EltaMD, Supergoop & ...

The MSc in Clinical Drug Development provides students with a multidisciplinary perspective to facilitate their skills. The programme is designed for individuals who need an understanding of drug ...

This course is based within the four pillars of advanced practice these being leadership, education, research and clinical practice. Whilst on the course you will develop skills in advanced health ...

These combination therapies aim to overcome resistance mechanisms, improve tumor targeting, and boost immune responses. Clinical studies have shown that such combinations can significantly improve ...

Sequential Infusion of Mesenchymal Stem Cell for Graft-Versus-Host Disease Prevention in Haploidentical Hematopoietic Stem Cell Transplantation: An Open-Label, Multicenter, Randomized Controlled ...

Bonus Jul 19, 1991 Aug 21, 1991 Sep 30, 1991 Bonus Ratio: 1 share(s) for every 2 shares held Bonus--Jun 22, 1987 Bonus Ratio: 1 share(s) for every 1 shares held Bonus--Jun 22, 1983 Bonus Ratio: 3 ...

The Institute of Clinical Trials and Methodology is the largest concentration of triallists in Europe, employing the best scientific minds across the broad field of clinical trials, working together ...

While venture funding is rising, federal policy upheaval may affect women’s health research more acutely than other fields, one biotech CEO said.

2017-010 Natural History Study Of The Development Of Type 1 Diabetes (Trialnet TN01) Blood draw to determine if a patient may be a risk factor for patients with a family history of Type 1 Diabetes.